Coronary Vasospasm Global Clinical Trials Review, H2, 2014

Date: August 20, 2014
Pages: 57
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C0EE251D2FFEN
Leaflet:

Download PDF Leaflet

Summary

GlobalData's clinical trial report, “Coronary Vasospasm Global Clinical Trials Review, H2, 2014' provides data on the Coronary Vasospasm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Coronary Vasospasm. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Coronary Vasospasm. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note:: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Coronary Vasospasm
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Coronary Vasospasm
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Coronary Vasospasm Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Clinical Trial Overview of Top Institutes / Government
Japanese Coronary Spasm Association
Clinical Trial Overview of Japanese Coronary Spasm Association
Robert Bosch Medical Center
Clinical Trial Overview of Robert Bosch Medical Center
Kyorin University
Clinical Trial Overview of Kyorin University
Kumamoto University
Clinical Trial Overview of Kumamoto University
National Institute of Health and Medical Research
Clinical Trial Overview of National Institute of Health and Medical Research
University of Nebraska
Clinical Trial Overview of University of Nebraska
Korea University
Clinical Trial Overview of Korea University
University Hospital Basel
Clinical Trial Overview of University Hospital Basel
Washington University School of Medicine
Clinical Trial Overview of Washington University School of Medicine
University of California, San Francisco
Clinical Trial Overview of University of California, San Francisco
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region, 2014*
Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014*
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014*
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase, 2014*
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Global, by End Point Status, 2014*
Coronary Vasospasm Therapeutics, Global, Suspended Clinical Trials, 2014*
Coronary Vasospasm Therapeutics, Global, Withdrawn Clinical Trials, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
Coronary Vasospasm Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Japanese Coronary Spasm Association, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert Bosch Medical Center, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Kumamoto University, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Health and Medical Research, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea University, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014*
Coronary Vasospasm Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2014*

LIST OF FIGURES

Coronary Vasospasm Therapeutics, Global, Clinical Trials by Region (%), 2014
Coronary Vasospasm Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Coronary Vasospasm Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014
Coronary Vasospasm Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Coronary Vasospasm Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, G7 Countries (%), 2014
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Coronary Vasospasm Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Coronary Vasospasm to Cardiovascular Clinical Trials, E7 Countries (%), 2014
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Phase (%), 2014
Coronary Vasospasm Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Coronary Vasospasm Therapeutics, Global, Clinical Trials by Trial Status, 2014
Coronary Vasospasm Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Coronary Vasospasm Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Coronary Vasospasm Therapeutics Clinical Trials, Global, Key Sponsors, 2014
GlobalData Methodology
Skip to top


Ask Your Question

Coronary Vasospasm Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: